Statement 27 May 2016

WHA 69, Agenda Item: 14.4 Global action plan on antimicrobial resistance

WHA 69, Item 14.4 Global action plan on antimicrobial resistance Delivered by Nina Grundmann, Associate Manager, Global Health Policy, IFPMA IFPMA commends WHO for presenting options for the establishment of a global development and stewardship framework and for its efforts to increase political awareness, engagement and leadership on AMR with the upcoming High Level Meeting...

Read more
Expert insight 27 May 2016

Smart Thinking for Healthy Lifestyles

This blog was originally posted in Diplomatic Courier Since the start of this millennium, we have witnessed many success stories in global health. Death from infectious diseases like malaria and tuberculosis have been cut in half. A child is twice as likely to survive past their fifth birthday than he or she was fifteen year ago....

Read more
Infographic 25 May 2016

Zika & Ebola: How global health threats prompt innovation (Visual recording of the panel discussion)

Read more
Position paper 25 May 2016

Pharmacy-mediated substitution for similar biotherapeutic products

‘Pharmacy-mediated substitution is defined as a framework permitting substitution of biotherapeutics at the pharmacy level without the consent of the prescribing physician. IFPMA believes there should be a distinction in public health policy between this type of substitution and the type of switching performed under medical supervision. The following policy position developed by IFPMA is...

Read more
Infographic 25 May 2016

Understanding psoriasis

Psoriasis was recognized for the first time as a serious non-communicable disease at the World Health Assembly in 2014. To help bring the public health impact of psoriasis into focus and to help raise awareness of the range of ways that psoriasis can affect peoples’ lives, IFPMA presents the recommendations from the WHO Global report...

Read more
Position paper 24 May 2016

IFPMA Guidelines on Access to Genetic Resources: position paper

Read more
Statement 19 May 2016

ABPI, EFPIA, and IFPMA issue joint statement on AMR

ABPI, EFPIA and IFPMA issue joint statement following publication of the final report by the Review on AMR The Association of the British Pharmaceutical Industry (ABPI), the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) have today issued a joint statement following the publication of...

Read more
Statement 18 May 2016

UN High-Level Panel on Access to Medicines – submissions A, B, C, 26 February 2016

Read more
Infographic 17 May 2016

Combating hypertension

Read more
Report 17 May 2016

Hypertension: putting the pressure on the silent killer

Read more
Press release 11 May 2016

Partnership launched to tackle cervical cancer in Africa

  Brazzaville/Kigali, 11 May 2016 – Ongoing efforts to prevent and control cervical cancer in the African Region have received a significant boost following the announcement of a pioneering partnership between the World Health Organization African Region (WHO AFRO) and the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA). The new partnership, “AFRO Comprehensive Cervical...

Read more
Infographic 11 May 2016

Improving the odds for early diagnosis of cervical cancer in Africa

Read more